Table 3.
Postoperative adverse events in PACU
| Variables | Group S (n = 68) | Group P (n = 67) | P-value |
|---|---|---|---|
| PONV required to use rescue antiemetics (n) | 1 | None | 0.994 |
| Hypertension events (%) | 3.0 | 2.9 | 0.977 |
| Hypotension events (%) | 4.1 | 6.4 | 0.17 |
| Tachycardia events (%) | 8.0* | 17.3 | ≤0.001 |
| Bradycardia events (%) | 7.8 | 10.7 | 0.156 |
| Incomplete reversal case with hypoxia (n) | None | 1 | 0.994 |
The patient data are presented as number of patients (n) or incidence of haemodynamic events (%). Group S: patients who received sugammadex as a reversal agent. Group P: patients who received pyridostigmine as a reversal agent
PACU post-anaesthesia care unit, PONV Postoperative nausea and vomiting
*P < 0.05 vs. group P